MYLIP

mutation — cross-omics
Cross-omicsMUTATION → DRUGCell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, MYLIP mutation is significantly associated with the drug of many other genes, with 6 significant associations in total. LARGE_INTESTINE shows the largest number of these associations.

The most reproducible MYLIP-associated genes across cancer lineages are GSK2801, SU11274, and Gallibiscoquinazole. Each is linked with MYLIP in more than 1 cancer types. Because this analysis shows association rather than direction, both MYLIP-to-partner and partner-to-MYLIP results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, GSK2801 grouped by MYLIP-low versus MYLIP-high in LARGE_INTESTINE.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (MYLIP→partner) and Y-score (partner→MYLIP) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LARGE_INTESTINEGSK2801 →+0.397+2.649.011.04631
LARGE_INTESTINESU11274 →+0.427+2.652.040.04531
LARGE_INTESTINEGallibiscoquinazole →+0.335+2.649.042.04621
LARGE_INTESTINECP724714 →+0.345+2.652.040.04521
LARGE_INTESTINEDacarbazine →+0.302+2.777.030.03811
LARGE_INTESTINE123138 →+0.341+2.649.020.04611
Each partner links to its Q-omics profile. Showing the 6 strongest of 6 associations by consensus.

GSK2801 by MYLIP expression — LARGE_INTESTINE

Box plot of GSK2801 in MYLIP-low vs MYLIP-high samples in LARGE_INTESTINE.

Explore this box plot interactively →

Exploration